Session Information

Sponsored Seminar

[IMS-TH-02] Morning Seminar 2: The Leading Edge of Regenerative Medicine: What Will Happen Over the Next Decade?
Go back
print
Day
Apr 03 (Thu)
Time
07:30 - 08:30
Room
Room 6 - Tokyo International Forum 5F Hall D5
Sponsor
Otsuka Pharmaceutical Co.,Ltd.
Topic
Cornea, Conjunctiva
Chair/Coordinator
Chair)Shigeru Kinoshita、Chair)Masayo Takahashi
Description
Tissue-engineering therapies aimed at treating various ophthalmology-related diseases have been anxiously anticipated. In this seminar, attendees will be provided with the latest information regarding recent advancements in regenerative medicine-based technology for the treatment of devastating ocular disorders, and tissue-engineering therapies for corneal epithelial and endothelial stem-cell dysfunction will be addressed. In addition, attendees will be introduced to a scheduled pilot study of induced pluripotent stem-cell-derived retinal pigment epithelium cell-sheet transplantation for the treatment of age-related macular degeneration. These important topics will help illustrate the latest knowledge and cutting-edge ideas towards future therapeutic modalities for the treatment of devastating ophthalmology-related diseases.

Go back